Drug Delivery Device Market, By Route of Administration (Injectable, Topical, Ocular, and Other Routes of Administration), By Application (Cancer, Cardiovascular, Diabetes, Infectious Diseases, and Other Applications), By End User (Hospitals, Ambulatory Surgical Centers, and Other End Users), and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
A drug delivery device is defined as the device used to deliver a therapeutic substance and enables a therapeutic substance to reach its site of action without reaching non-target cells, organs, and/or tissues. These devices are used as part of one or more medical treatments to delivery a drug or a therapeutic agent via a specific route of administration.
Market Dynamics:
Increasing burden of chronic/non-communicable diseases, increasing adoption of technologically advanced drug delivery devices, rapid growth in the biologics market, and the outbreak of COVID-19 are major factors expected to drive growth of the global drug delivery device market.
For instance, in September 2022, Corium, Inc. announced that ADLARITY (donepezil transdermal system) is now available for prescription in the United States for the treatment of people with mild, moderate, or severe dementia of Alzheimer's type. Moreover, in February 2022, Takeda received the U.S. Food and Drug Administration (USFDA) approval for TAKHZYRO (lanadelumab-flyo) injection single-dose prefilled syringe, which is used to prevent attacks of hereditary angioedema (HAE) in adult and pediatric patients 12 years of age and older.
Key features of the study:
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook